Can gallbladder ejection fraction measured by fatty meal cholescitigraphy diagnose chronic cholecystitis?

Authors

  • Ali Jangjoo Department of Surgery, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Elahe Mohammadi Vosoughi Islamic Azad University of Mashhad, Mashhad, Iran
  • Kamran Aryana Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Masoud Pezeshki-Rad Department of Radiology, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mehdi Farzadnia Department of Pathology, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Ramin Sadeghi Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Seyed Rasoul Zakavi Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Yasmin Davoudi Department of Radiology, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

  Introduction: Despite presence of a body of evidence in support of high accuracy of cholecystokinin cholescintigraphy (CCK-CS) , for diagnosis of chronic cholecystitis(CC) , some authors have claimed that  gallbladder ejection fraction (GBEF)  has poor predictive diagnostic values. The purpose of this study was to determine if there is any difference in GBEF between normal individuals and patients with CC. Methods: In a prospective case-control study, we studied 36 subjects as control group who did not have any abdominal symptoms, or history of abdominal disease or gallstone. Patients group were 42 with established choronic calcalous cholecystitis(CCC)  who complaining of chronic biliary-like pain and had gallstone on ultrasonography.  All subjects underwent gallbladder scintigraphy and GBEF was calculated at 30 and 60 minutes after fatty meal (FM) ingestion. Results: In control group GBEF at 30-minute and at 60-minute after FM ingestion were 69.54%±21.04% and 84.26%±11.41% respectively while in patients group GBEF at 30-minute  was 61.21%±16.01%  and at 60-minute was 80.22%±12.57%. No significant difference was noticed between control and patient groups. GBEF didn't show significant difference between different groups based on the number of gallbladder stone, severity of chronic inflammatory (lymphoplasma) cell infiltration, wall thickness and evidence of fibrosis in the gallbladder wall. Conclusion: Our data are against the diagnostic value of the GBEF as measured by FM-CS in the workup of patients with CC. Thus, interpretation of GBEF should take the proper clinical context into consideration.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

can gallbladder ejection fraction measured by fatty meal cholescitigraphy diagnose chronic cholecystitis?

introduction: despite presence of a body of evidence in support of high accuracy of cholecystokinin cholescintigraphy (cck-cs) , for diagnosis of chronic cholecystitis(cc) , some authors have claimed that  gallbladder ejection fraction (gbef)  has poor predictive diagnostic values. the purpose of this study was to determine if there is any difference in gbef between normal individuals and patie...

full text

Fatty meal ultrasonography in chronic acalculous cholecystitis

Chronic acalculous cholecystits typically presents with biliary symptoms, normal blood tests and unremarkable ultrasound, computerized tomography and magnetic resonance cholangiopancreatography. However, cholescintigraphy may show reduced gallbladder ejection fraction (GBEF). There are no reports on using ultrasound to measure GBEF in adults. Twenty-eight patients with the above presentation un...

full text

Comparison of fatty meal and intravenous cholecystokinin infusion for gallbladder ejection fraction.

UNLABELLED Gallbladder ejection fraction (GBEF) measured with a fatty meal (half-and-half milk) was compared with that measured with 2 equal sequential intravenous infusions of cholecystokinin (CCK-8) in a paired study of healthy subjects. METHODS GBEF was measured by (99m)Tc-hepatic iminodiacetic acid cholescintigraphy in 13 healthy subjects. Each subject received 2 sequential doses of CCK-8...

full text

Normal values of gallbladder ejection fraction using 99mTc-sestamibi scintigraphy after a fatty meal formula.

BACKGROUND AND AIMS Sincalide, in conjunction with cholescintigraphy, is necessary for the diagnosis of chronic acalculous cholecystitis. However sincalide is not widely available. This study investigates the use of a commercially available formula as an inexpensive alternative to sincalide, containing a sufficient and known amount of fat to cause gallbladder contraction, and to determine norma...

full text

Can Biomarkers Help to Diagnose Early Heart Failure with Preserved Ejection Fraction?

Early heart failure with preserved ejection fraction (HFpEF) is a frequent disease, but its diagnosis is difficult and relies mostly on the evidence of left ventricular filling pressure (LVFP) elevation during exercise. Several reports have suggested that natriuretic peptides plasma levels reflect exercise-induced increase in LVFP, but they still have significant limitations. In this context, a...

full text

Usefulness of fatty meal-stimulated cholescintigraphy in the diagnosis and treatment of chronic acalculous cholecystitis.

OBJECTIVE Fatty meal cholescintigraphy (fatty meal CS) is a potential physiologic alternative for cholecystokinin (CCK) CS in the diagnosis and treatment of chronic acalculous cholecystitis (CAC). However, there are limited data in the literature to support this assumption. Our objective was to determine the usefulness of fatty meal CS in the diagnosis and treatment of CAC. METHODS We retrosp...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 19  issue 1

pages  30- 39

publication date 2011-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023